12:00 AM
Sep 17, 2012
 |  BC Week In Review  |  Company News  |  Deals

Critical Outcome Technologies, University of Western Ontario deal

Critical Outcome will use its CHEMSAS computational drug design technology to discover compounds against a target selected by a university researcher to treat CNS scarring following...

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >